WHO ICTRP trial
Cetuximab in Treating Patients With Recurrent or Progressive Metastatic…
NCT00118118 · NIH Clinical Trials · Not recruiting
Key facts
| Trial ID | NCT00118118 |
|---|---|
| Public title | Cetuximab in Treating Patients With Recurrent or Progressive Metastatic Non-Small Cell Lung Cancer |
| Scientific title | An Exploratory Pharmacogenomics Study of Erbitux® Monotherapy in Patients With Metastatic Non-Small Cell Lung Carcinoma |
| Primary sponsor | Jonsson Comprehensive Cancer Center |
| Secondary sponsors | National Cancer Institute (NCI) |
| Registry | NIH Clinical Trials |
| Recruitment status | Not recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | United States |
| Conditions | Lung Cancer |
| Interventions | Biological: cetuximab |
| Registration date | Aug 7, 2005 |
| Secondary IDs | UCLA-0409029-01;BMS-CA225065;CDR0000433489 |
| Registry page | clinicaltrials.gov |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: